These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32378663)

  • 1. [Development of Nano-DDS Carriers for Control of Spatial Distribution Using Multi-color Deep Imaging].
    Kawakami S; Suga T
    Yakugaku Zasshi; 2020; 140(5):633-640. PubMed ID: 32378663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model.
    Suga T; Kato N; Hagimori M; Fuchigami Y; Kuroda N; Kodama Y; Sasaki H; Kawakami S
    Mol Pharm; 2018 Oct; 15(10):4481-4490. PubMed ID: 30179010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of New Liposome Targeting Strategies for Application of Disease Therapies].
    Shimizu K
    Yakugaku Zasshi; 2017; 137(1):43-48. PubMed ID: 28049894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
    Oku N
    Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
    Saravanakumar K; Hu X; Ali DM; Wang MH
    Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the intestinal lymph by oral formulations.
    Yoshida T; Kojima H; Sako K; Kondo H
    Pharm Dev Technol; 2022 Feb; 27(2):175-189. PubMed ID: 35037843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer.
    Allen TM; Cheng WW; Hare JI; Laginha KM
    Anticancer Agents Med Chem; 2006 Nov; 6(6):513-23. PubMed ID: 17100556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Screening System for Targeting Carriers Using Peptide-Modified Liposomes and Tissue Sections.
    Negishi Y; Hamano N; Sato H; Katagiri F; Takatori K; Endo-Takahashi Y; Kikkawa Y; Nomizu M
    Biol Pharm Bull; 2018; 41(7):1107-1111. PubMed ID: 29962407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug transport kinetics of intravascular triggered drug delivery systems.
    Ten Hagen TLM; Dreher MR; Zalba S; Seynhaeve ALB; Amin M; Li L; Haemmerich D
    Commun Biol; 2021 Jul; 4(1):920. PubMed ID: 34321602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of a Nano DDS for Cancer Immunotherapy Based on Llipid Nanoparticles].
    Nakamura T
    Yakugaku Zasshi; 2018; 138(12):1443-1449. PubMed ID: 30504656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
    Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
    Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
    Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
    Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes in biology and medicine.
    Schwendener RA
    Adv Exp Med Biol; 2007; 620():117-28. PubMed ID: 18217339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal Studies.
    Alkaff SA; Radhakrishnan K; Nedumaran AM; Liao P; Czarny B
    Int J Nanomedicine; 2020; 15():445-464. PubMed ID: 32021190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive and Active Drug Targeting: Role of Nanocarriers in Rational Design of Anticancer Formulations.
    Das RP; Gandhi VV; Singh BG; Kunwar A
    Curr Pharm Des; 2019; 25(28):3034-3056. PubMed ID: 31470779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances on Cellulose-Based Nano-Drug Delivery Systems: Design of Prodrugs and Nanoparticles.
    Dai L; Si C
    Curr Med Chem; 2019; 26(14):2410-2429. PubMed ID: 28699504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview.
    Liu X; Cheng Y; Mu Y; Zhang Z; Tian D; Liu Y; Hu X; Wen T
    Front Immunol; 2024; 15():1328145. PubMed ID: 38298192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the dynamics of drug delivery systems (DDS) using intravital real-time confocal laser scanning microscopy].
    Nomoto T; Matsumoto Y; Toh K; Christie RJ; Miyata K; Oba M; Cabral H; Murakami M; Fukushima S; Nishiyama N; Kataoka K
    Yakugaku Zasshi; 2012; 132(12):1347-54. PubMed ID: 23208040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.